FDA Clears New Single Lead ICD with Atrial Sensing
Published date : 26 February 2013
Article date : 26 February 2013
Medgadget reports that medical device manufacturer, BIOTRONIK, has gained FDA approval for the Lumax 740 DX System. The implantable cardioverter defibrillator is the first in the world that will allow certain patients the benefit of atrial sensing without the requirement for a second wire to run through the heart.
They say that the system uses a Linoxsmart S DX lead which features a floating atrial dipole and algorithms that can differentiate between supraventricular tachycardias, AF and atrial flutter.
The system is compatible with BIOTRONIK’s wireless Home Monitoring platform that keeps physicians updated about any relevant events detected by the implant.
Source: Gene Ostrovsky, Medgadget, 24 February 2013
